Supplementary Financial Information (Tables)

6 Months Ended

Jun. 30, 2025

Supplemental Financial Information [Abstract]

Schedule of Restricted Cash

Cash, cash equivalents and restricted cash amounts are as follows:

	June 30, 2025		December 31, 2024
Cash and cash equivalents	$	449	$	576
Restricted cash
Debt proceeds held in escrow	492		—
Litigation deposits in Brazil	23		20
Escrow and cash collections related to secured borrowing arrangements and receivable sales	1		13
Other restricted cash	20		22
Total Restricted cash	536		55
Cash, cash equivalents and restricted cash	$	985	$	631

Schedule of Restricted Cash Balance Sheet Location

Restricted cash is reported in the Condensed Consolidated Balance Sheets as follows:

	June 30, 2025		December 31, 2024
Other current assets	$	511	$	33
Other long-term assets	25		22
Total Restricted cash	$	536	$	55

Schedule of Cash Flow Information

Summarized cash flow information is as follows:

	Location in Statement of Cash Flows	Six Months Ended June 30,
Source/(Use)		2025		2024
Provision for receivables (1)	Operating	$	27	$	24
Provision for inventory	Operating	21		55
Depreciation of buildings and equipment	Operating	27		27
Depreciation and obsolescence of equipment on operating leases	Operating	59		57
Amortization of internal use software	Operating	11		14
Amortization of acquired intangible assets	Operating	20		20
Amortization of patents(2)	Operating	4		5
Amortization of customer contract costs(3)	Operating	33		32
Cost of additions to land, buildings and equipment	Investing	(9)		(14)
Cost of additions to internal use software	Investing	(30)		(4)
Payments to acquire noncontrolling interests - Xerox Holdings	Investing	(4)		(20)
Common stock dividends - Xerox Holdings	Financing	(51)		(64)
Preferred stock dividends - Xerox Holdings	Financing	(7)		(7)
Repurchases related to stock-based compensation - Xerox Holdings	Financing	(6)		(10)
Commitment fees	Financing	(15)		—
Finance lease obligations	Financing	(7)		(2)

_____________

(1)Provision for receivables includes adjustments for customer accommodations and contract terminations of $2 and $0 for the three months ended June 30, 2025 and 2024, respectively and $3 and (1) for the six months ended June 30, 2025 and 2024, respectively.

(2)Amortization of patents is reported in Decrease in other current and long-term assets in the Condensed Consolidated Statements of Cash Flows.

(3)Amortization of customer contract costs is reported in Decrease in other current and long-term assets in the Condensed Consolidated Statements of Cash Flows. Refer to Note 3 - Revenue - Contract Costs for additional information.

Schedule of Supplier Finance Program

The Company's supplier finance program is as follows:

	2025		2024
Balance at January 1st	$	30	$	40
Amounts invoiced	22		30
Invoices paid	(33)		(40)
Balance at March 31st	$	19	$	30
Amounts invoiced	22		30
Invoices paid	(21)		(35)
Balance at June 30th	$	20	$	25